Recommendations for Testing, Managing, and Treating Hepatitis C

Abstract

New direct-acting oral agents capable of curing hepatitis C virus (HCV) infection have been approved for use in the United States. The initial direct-acting agents were approved in 2011, and many more oral drugs are expected to be approved in the next few years. As new information is presented at scientific conferences and published in peer-reviewed journals, health care practitioners have expressed a need for a credible source of unbiased guidance on how best to treat their patients with HCV infection.

Recommendations

For more information on the recommendations of this guideline, please visit HCVGuidelines.org.